Novo Nordisk's partnership with OpenAI will “help the company bring new and better treatment options to patients faster,” the Danish pharmaceutical company announced on Tuesday. The collaboration will ...
OpenAI published a substantial update to GPT-Rosalind on June 3, 2026, deepening the domain-specialized model's performance across drug discovery, genomics, and wet-lab research — and opening the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results